Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).

A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS).

Effectiveness and safety of risankizumab in HIV patients with psoriasis: A case series.

Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices.

Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma.

Validation of an ELISA method for determination of physical particle titre of AAV2-based vector preparations.

Establishment of hepatitis A virus coating reagent batch 2 for in vitro potency assay of hepatitis A vaccines by ELISA.

Establishment of Erythropoietin for physicochemical tests CRS batch 2.

Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series.

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience.